Proposed Data Collection Submitted for Public Comment and Recommendations, 11532-11533 [2021-03924]
Download as PDF
<![CDATA[
11532
Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by February 26, 2021. To accommodate
the significant interest in participation
in the oral public comment session of
ACIP meetings, each speaker will be
limited to 3 minutes, and each speaker
may only speak once per meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–03959 Filed 2–23–21; 11:15 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–21DC; Docket No. CDC–2021–
0012]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘National Syringe Services
Program (SSP) Evaluation’, which
proposes to: (1) Assess and monitor SSP
operational characteristics and services,
client characteristics and drug use
patterns, client satisfaction, funding
resources, community relations, and key
SUMMARY:
VerDate Sep<11>2014
17:04 Feb 24, 2021
Jkt 253001
operational and programmatic successes
and challenges and (2) support timely
analysis and dissemination of national
program evaluation survey findings.
DATES: CDC must receive written
comments on or before April 26, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0012 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
National Syringe Services Program
(SSP) Evaluation—New—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The primary purpose of the National
Syringe Services Program (SSP)
Evaluation is to strengthen and improve
the capacity of SSPs to conduct regular
monitoring and evaluation to ensure
that comprehensive prevention services
are provided to meet the needs of
people who inject drugs (PWID) and
reduce infectious disease and other
harms related to intravenous drug use
(IDU). The project will invite the
participation of all SSPs that are listed
in a publicly available directory of all
known SSPs in the United States
maintained by the North American
Syringe Exchange Network (NASEN;
https://nasen.org). SSPs will be sent a
letter of invitation to participate in a 35minute program survey. Participating
programs will have the option of
completing the survey via different
modalities to enhance feasibility and
comfort in completing the survey, for
example via the Research Electronic
Data Capture (REDCap) or a similarly
secure web-based application. Other
modalities for survey administration
will include a coordinated telephone or
videoconferencing interview. SSPs will
be sent reminder letters for an
approximately three-month data
collection period. SSPs that do not
respond to prior reminders will be sent
one final reminder, and if the SSP still
does not want to participate, one
(optional) question on why the SSP did
not complete the survey will be offered.
The survey will include questions on
operational characteristics and services,
client characteristics and drug use
patterns, client satisfaction, funding
resources, community relations, and key
operational successes and challenges.
Approximately 400 SSPs will be able to
E:\FR\FM\25FEN1.SGM
25FEN1
11533
Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices
participate in the survey. We anticipate
that approximately 20% of SSPs will
decline to complete the survey, yielding
approximately 320 completed surveys
per year. However, given that this is the
first survey of SSPs funded by CDC and
that the COVID–19 pandemic makes it
challenging to predict future response
rates, we are requesting enough burden
hours to allow 100% of SSPs to respond
to the survey. We estimate that it will
take 35 minutes to complete the survey,
regardless of how the respondent
described above, we are requesting
enough burden hours to allow 100% of
SSPs to respond to this question. We
estimate that it will take two minutes to
respond to this question.
OMB approval is requested for three
years. The survey will be administered
annually using the most updated
national directory of SSPs during each
survey administration. Participation is
voluntary and there are no costs to
respondents other than their time.
chooses to complete it (i.e., selfadministered online or intervieweradministered by phone or
videoconferencing). SSPs that do not
respond to the initial survey invitation
will be given reminders to complete the
survey over the duration of the survey
implementation period. The final
reminder will include a link to a single
question for SSPs that choose not to
complete the survey about why they
declined to complete the survey. Given
the uncertainties in response rates
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondent
Form
All participating SSPs .......................
400
1
35/60
233
Non-responding SSPs ......................
National Syringe Services Program
Evaluation Survey.
Non-Response Survey Item .............
400
1
2/60
13
Total ...........................................
...........................................................
........................
........................
........................
246
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–03924 Filed 2–24–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–1266; Docket No. CDC–2021–
0014]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘HIV prevention among Latina
transgender women who have sex with
men: Evaluation of a locally developed
intervention’’. The collection is part of
a research study designed to evaluate
SUMMARY:
VerDate Sep<11>2014
17:04 Feb 24, 2021
Jkt 253001
the efficacy of a locally developed and
culturally congruent two-session
Spanish-language small-group
intervention, ChiCAS (Chicas Creando
Acceso a la Salud [Chicas: Girls Creating
Access to Health]), which provides
combination HIV prention services to
adult Hispanic/Latina transgender
women at high risk for HIV infection.
DATES: CDC must receive written
comments on or before April 26, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2121–
0014 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
SUPPLEMENTARY INFORMATION:
E:\FR\FM\25FEN1.SGM
25FEN1
]]>Agencies
[Federal Register Volume 86, Number 36 (Thursday, February 25, 2021)]
[Notices]
[Pages 11532-11533]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03924]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-21DC; Docket No. CDC-2021-0012]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled `National Syringe Services
Program (SSP) Evaluation', which proposes to: (1) Assess and monitor
SSP operational characteristics and services, client characteristics
and drug use patterns, client satisfaction, funding resources,
community relations, and key operational and programmatic successes and
challenges and (2) support timely analysis and dissemination of
national program evaluation survey findings.
DATES: CDC must receive written comments on or before April 26, 2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0012 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
National Syringe Services Program (SSP) Evaluation--New--National
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The primary purpose of the National Syringe Services Program (SSP)
Evaluation is to strengthen and improve the capacity of SSPs to conduct
regular monitoring and evaluation to ensure that comprehensive
prevention services are provided to meet the needs of people who inject
drugs (PWID) and reduce infectious disease and other harms related to
intravenous drug use (IDU). The project will invite the participation
of all SSPs that are listed in a publicly available directory of all
known SSPs in the United States maintained by the North American
Syringe Exchange Network (NASEN; https://nasen.org). SSPs will be sent
a letter of invitation to participate in a 35-minute program survey.
Participating programs will have the option of completing the survey
via different modalities to enhance feasibility and comfort in
completing the survey, for example via the Research Electronic Data
Capture (REDCap) or a similarly secure web-based application. Other
modalities for survey administration will include a coordinated
telephone or videoconferencing interview. SSPs will be sent reminder
letters for an approximately three-month data collection period. SSPs
that do not respond to prior reminders will be sent one final reminder,
and if the SSP still does not want to participate, one (optional)
question on why the SSP did not complete the survey will be offered.
The survey will include questions on operational characteristics
and services, client characteristics and drug use patterns, client
satisfaction, funding resources, community relations, and key
operational successes and challenges. Approximately 400 SSPs will be
able to
[[Page 11533]]
participate in the survey. We anticipate that approximately 20% of SSPs
will decline to complete the survey, yielding approximately 320
completed surveys per year. However, given that this is the first
survey of SSPs funded by CDC and that the COVID-19 pandemic makes it
challenging to predict future response rates, we are requesting enough
burden hours to allow 100% of SSPs to respond to the survey. We
estimate that it will take 35 minutes to complete the survey,
regardless of how the respondent chooses to complete it (i.e., self-
administered online or interviewer-administered by phone or
videoconferencing). SSPs that do not respond to the initial survey
invitation will be given reminders to complete the survey over the
duration of the survey implementation period. The final reminder will
include a link to a single question for SSPs that choose not to
complete the survey about why they declined to complete the survey.
Given the uncertainties in response rates described above, we are
requesting enough burden hours to allow 100% of SSPs to respond to this
question. We estimate that it will take two minutes to respond to this
question.
OMB approval is requested for three years. The survey will be
administered annually using the most updated national directory of SSPs
during each survey administration. Participation is voluntary and there
are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs........ National Syringe 400 1 35/60 233
Services
Program
Evaluation
Survey.
Non-responding SSPs........... Non-Response 400 1 2/60 13
Survey Item.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 246
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-03924 Filed 2-24-21; 8:45 am]
BILLING CODE 4163-18-P
